Glenmark

Mumbai, July 17 (UNI) Glenmark Pharmaceutical (UK) and the Merck Generics Group (Merck Generics) have tied-up for the joint development, filing and marketing of eight generic dermatological products for Europe, with a sales value of around USD 225 mn in the region.

Informing the BSE, Glenmark said as per the agreement, they will develop, manufacture and supply the products while both the companies would be responsible for their own sales and marketing. The first of these products has already been filed and is targeted to be launched next year; the remaining products are slated to be launched by 2010.

Glenmark's MD and CEO Glenn Saldanha said, ''We are happy to partner with Merck Generics, which has a strong sales presence in Europe. Moreover, our association is a testament to Glenmark's combined strengths in dermatology and research and development.'' UNI SN GK SKB1815